Literature DB >> 19073524

Pathobiology of mature T-cell lymphomas.

Claudiu V Cotta1, Eric D Hsi.   

Abstract

Mature T- and natural killer (NK)-cell neoplasms are relatively rare forms of leukemia/lymphoma. The diagnosis of these entities is often difficult, necessitating extensive immunophenotypic, molecular, and genetic testing. Despite the accumulating information on the pathobiology of these neoplasms, in many cases the prognosis remains poor. This article presents an updated view of the morphologic, immunophenotypic, genetic, and molecular characteristics of the mature T- and NK-cell neoplasms. For a better understanding of this complex topic, the development of normal T and NK cells is briefly discussed. The presentation of the characteristic features of the neoplasms in the 2008 World Health Organization classification of hematopoietic neoplasms includes advances in the understanding of the pathobiology of each diagnostic category.

Entities:  

Mesh:

Year:  2008        PMID: 19073524     DOI: 10.3816/CLM.2008.s.013

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN: 1557-9190


  3 in total

1.  Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project.

Authors:  Eric D Hsi; Jonathan Said; William R Macon; Scott J Rodig; Sarah L Ondrejka; Randy D Gascoyne; Elizabeth A Morgan; David M Dorfman; Matthew J Maurer; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

2.  Peripheral T cell lymphoma: new model + new insight.

Authors:  James C Mulloy
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

3.  The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.

Authors:  Konstanze Pechloff; Julian Holch; Uta Ferch; Marc Schweneker; Kristina Brunner; Markus Kremer; Tim Sparwasser; Leticia Quintanilla-Martinez; Ursula Zimber-Strobl; Berthold Streubel; Andreas Gewies; Christian Peschel; Jürgen Ruland
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.